anmelden
FTSE All-Share
5.504,53
PKT
-21,74
PKT
-0,39
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 16.02.26 | Vodafone Group Sell | Goldman Sachs Group Inc. | |
| 16.02.26 | AstraZeneca Sell | Deutsche Bank AG | |
| 13.02.26 | AstraZeneca Outperform | Bernstein Research | |
| 13.02.26 | GSK Buy | Jefferies & Company Inc. | |
| 12.02.26 | AstraZeneca Halten | DZ BANK | |
| 12.02.26 | BAT Neutral | JP Morgan Chase & Co. | |
| 12.02.26 | BAT Underperform | RBC Capital Markets | |
| 12.02.26 | BAT Buy | Jefferies & Company Inc. | |
| 11.02.26 | London Stock Exchange (LSE) Overweight | Barclays Capital | |
| 11.02.26 | BP Buy | Goldman Sachs Group Inc. | |
| 11.02.26 | BP Neutral | UBS AG | |
| 11.02.26 | AstraZeneca Sell | Deutsche Bank AG | |
| 11.02.26 | AstraZeneca Overweight | Barclays Capital | |
| 11.02.26 | BP Sector Perform | RBC Capital Markets | |
| 11.02.26 | BP Neutral | JP Morgan Chase & Co. | |
| 10.02.26 | BP Kaufen | DZ BANK | |
| 10.02.26 | Unilever Overweight | JP Morgan Chase & Co. | |
| 10.02.26 | Vodafone Group Kaufen | DZ BANK | |
| 10.02.26 | Rio Tinto Neutral | UBS AG | |
| 10.02.26 | AstraZeneca Buy | UBS AG | |
| 10.02.26 | BP Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 10.02.26 | BP Hold | Jefferies & Company Inc. | |
| 10.02.26 | AstraZeneca Overweight | Barclays Capital | |
| 10.02.26 | BP Overweight | Barclays Capital | |
| 10.02.26 | AstraZeneca Buy | Jefferies & Company Inc. | |
| 10.02.26 | BP Sector Perform | RBC Capital Markets | |
| 10.02.26 | AstraZeneca Outperform | Bernstein Research | |
| 10.02.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 10.02.26 | National Grid Buy | Jefferies & Company Inc. | |
| 09.02.26 | Shell (ex Royal Dutch Shell) Sector Perform | RBC Capital Markets | |
| 09.02.26 | Shell (ex Royal Dutch Shell) Overweight | Barclays Capital | |
| 09.02.26 | Unilever Overweight | Barclays Capital | |
| 09.02.26 | Unilever Hold | Deutsche Bank AG | |
| 06.02.26 | Shell (ex Royal Dutch Shell) Overweight | JP Morgan Chase & Co. | |
| 06.02.26 | Shell (ex Royal Dutch Shell) Buy | Goldman Sachs Group Inc. | |
| 06.02.26 | AstraZeneca Sell | Deutsche Bank AG | |
| 06.02.26 | GSK Underweight | JP Morgan Chase & Co. | |
| 06.02.26 | Rio Tinto Overweight | JP Morgan Chase & Co. | |
| 17.02.26 | Rio Tinto Overweight | JP Morgan Chase & Co. | |
| 06.02.26 | Shell (ex Royal Dutch Shell) Neutral | UBS AG |